http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003105023-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate | 2002-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d1b495fbc5173549f3e612f8204642f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd5c3ff84c71e8dcf13e5544df01c873 |
| publicationDate | 2003-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2003105023-A1 |
| titleOfInvention | Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
| abstract | Compounds of formula (SEQ ID NO:2) and (SEQ ID NO:3), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis. |
| priorityDate | 2001-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 584.